BHARAT BIOTECH

In News

Indian Vaccine Maker Bharat Biotech Is Said to Mull $500 Million IPO - Bloomberg.com

Bloomberg.com - Feb 27, 2026

GSK, Bharat Biotech to slash the price of first malaria vaccine to less than $5 per dose by 2028 - Fierce Pharma

Fierce Pharma - Jun 25, 2025

Bharat Biotech forays into CRDMO space with new cell & gene therapies arm Nucelion Therapeutics - The Times of India

The Times of India - Nov 03, 2025

GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development - GSK

GSK - Jun 12, 2025

Bharat Biotech launches Next-Gen Cell and Gene Therapy CRDMO Nucelion - BioSpectrum India

BioSpectrum India - Nov 03, 2025

Covaxin Maker Bharat Biotech Considers IPO, Likely to Raise $500 Mn - outlookbusiness.com

outlookbusiness.com - Feb 27, 2026

Bharat Biotech celebrates three decades of scientific excellence and global vaccine leadership - Express Pharma

Express Pharma - Mar 17, 2026

Bharat Biotech acquires licence to develop GSK's Shigella vaccine - Pharmaceutical Technology

Pharmaceutical Technology - Jun 13, 2025

Biofabri, Bharat Biotech ink tech transfer pact for MTBVAC tuberculosis vaccine - The Hindu

The Hindu - Dec 22, 2025

Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growth - The Economic Times

The Economic Times - Mar 18, 2026

Bharat, GSK to halve price of malaria vaccine by 2028 - Reuters

Reuters - Jun 25, 2025

GSK offloads shigella vaccine to Bharat ahead of phase 3, vows to support fundraising - Fierce Biotech

Fierce Biotech - Jun 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment